| Literature DB >> 27026084 |
Pia Kiilerich1, Lene Secher Myrmel2, Even Fjære2, Qin Hao1, Floor Hugenholtz3, Si Brask Sonne1, Muriel Derrien3, Lone Møller Pedersen1, Rasmus Koefoed Petersen1, Alicja Mortensen4, Tine Rask Licht4, Maria Unni Rømer5, Ulla Birgitte Vogel6, Linn Jeanette Waagbø7, Natasa Giallourou3, Qiang Feng8, Liang Xiao8, Chuan Liu8, Bjørn Liaset7, Michiel Kleerebezem9, Jun Wang10, Lise Madsen11, Karsten Kristiansen12.
Abstract
Female C57BL/6J mice were fed a regular low-fat diet or high-fat diets combined with either high or low protein-to-sucrose ratios during their entire lifespan to examine the long-term effects on obesity development, gut microbiota, and survival. Intake of a high-fat diet with a low protein/sucrose ratio precipitated obesity and reduced survival relative to mice fed a low-fat diet. By contrast, intake of a high-fat diet with a high protein/sucrose ratio attenuated lifelong weight gain and adipose tissue expansion, and survival was not significantly altered relative to low-fat-fed mice. Our findings support the notion that reduced survival in response to high-fat/high-sucrose feeding is linked to obesity development. Digital gene expression analyses, further validated by qPCR, demonstrated that the protein/sucrose ratio modulated global gene expression over time in liver and adipose tissue, affecting pathways related to metabolism and inflammation. Analysis of fecal bacterial DNA using the Mouse Intestinal Tract Chip revealed significant changes in the composition of the gut microbiota in relation to host age and dietary fat content, but not the protein/sucrose ratio. Accordingly, dietary fat rather than the protein/sucrose ratio or adiposity is a major driver shaping the gut microbiota, whereas the effect of a high-fat diet on survival is dependent on the protein/sucrose ratio.Entities:
Keywords: gut microbiota; high-fat diet; high-protein diet; obesity; survival
Mesh:
Substances:
Year: 2016 PMID: 27026084 DOI: 10.1152/ajpendo.00363.2015
Source DB: PubMed Journal: Am J Physiol Endocrinol Metab ISSN: 0193-1849 Impact factor: 4.310